Fraction Dose Escalation of Split-course Hypofractionated Concurrent Chemoradiotherapy Following Induction Chemo-immunotherapy in Unresectable Locally Advanced Esophageal Squamous Carcinoma: a Phase I Study.
Condition: Esophageal Squamous Cell Carcinoma Interventions: Radiation: Split-course hypo-CCRT; Drug: Induction chemo-immunotherapy; Drug: Concurrent chemotherapy Sponsor: Sun Yat-sen University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Chemotherapy | Esophagus Cancer | Immunotherapy | Research | Study